Transcriptomic analysis of autistic brain reveals convergent molecular pathology
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index; 19 of the 32 sources its claims cite were checked for support.
Abstract
Autism spectrum disorder (ASD) is a common, highly heritable neurodevelopmental condition characterized by marked genetic heterogeneity. Thus, a fundamental question is whether autism represents an aetiologically heterogeneous disorder in which the myriad genetic or environmental risk factors perturb common underlying molecular pathways in the brain. Here, we demonstrate consistent differences in transcriptome organization between autistic and normal brain by gene co-expression network analysis. Remarkably, regional patterns of gene expression that typically distinguish frontal and temporal cortex are significantly attenuated in the ASD brain, suggesting abnormalities in cortical patterning. We further identify discrete modules of co-expressed genes associated with autism: a neuronal module enriched for known autism susceptibility genes, including the neuronal specific splicing factor A2BP1 (also known as FOX1), and a module enriched for immune genes and glial markers. Using high-throughput RNA sequencing we demonstrate dysregulated splicing of A2BP1-dependent alternative exons in the ASD brain. Moreover, using a published autism genome-wide association study (GWAS) data set, we show that the neuronal module is enriched for genetically associated variants, providing independent support for the causal involvement of these genes in autism. In contrast, the immune-glial module showed no enrichment for autism GWAS signals, indicating a non-genetic aetiology for this process. Collectively, our results provide strong evidence for convergent molecular abnormalities in ASD, and implicate transcriptional and splicing dysregulation as underlying mechanisms of neuronal dysfunction in this disorder.
Overview
CoChat Summary
TL;DR
This study used post-mortem brain transcriptomics and co-expression network analysis to show that autism spectrum disorder (ASD) cortex has convergent molecular abnormalities, including attenuated frontal-temporal regional expression differences and distinct neuronal and immune-glial co-expression modules. It further links a down-regulated neuronal module to autism genetic association signals and demonstrates A2BP1-dependent differential splicing in ASD brain.
Key findings
- In autism cortex, 444 genes were differentially expressed (DE) versus controls, while only 2 genes were DE in cerebellum; the 209 down-regulated genes were enriched for synaptic function and the 235 up-regulated genes for immune/inflammatory response. In an independent BA44/45 replication cohort, 97 genes were DE and 81 overlapped with the initial cohort (p=1.2E-93), with the same direction of change for all but 2 of the 81.
- Regional cortical patterning was attenuated in ASD: 174 genes were DE between control BA9 and BA41 at FDR<1%, but none were DE in the same regional comparison among ASD cases; relaxing to FDR 5% identified over 500 DE genes in controls and only 8 in ASD brains.
- Weighted gene co-expression network analysis identified an under-expressed neuronal module (M12) enriched for known autism susceptibility genes (p=6.1E-4), including CADPS2, AHI1, CNTNAP2, and SLC25A12, and an up-regulated immune-glial module (M16). M12 showed significant enrichment for autism GWAS association signals (p=5E-4), whereas M16 and the DE gene list did not.
- RNA-Seq on 3 ASD samples with low A2BP1 and 3 controls identified 212 significant alternative splicing events; 36 overlapped with predicted A2BP1/2 targets (p=2.2E-16), and RT-PCR confirmed 85% of tested differential splicing changes involving predicted A2BP1 targets.
Methods
- Post-mortem brain tissue was obtained from the Autism Tissue Project, Harvard Brain Bank, and MRC London Brain Bank. Illumina microarrays profiled superior temporal gyrus (BA41/42), prefrontal cortex (BA9), and cerebellar vermis; after filtering, 58 cortex samples (29 ASD, 29 controls) and 21 cerebellum samples (11 ASD, 10 controls) were analyzed, with an independent BA44/45 replication cohort of 9 ASD cases and 5 controls.
- Analyses included differential expression, supervised hierarchical clustering, weighted gene co-expression network analysis (WGCNA), gene ontology enrichment, and GWAS set enrichment using a published autism GWAS dataset plus negative-control GWAS datasets.
- High-throughput RNA-Seq was performed on 3 ASD samples with significant A2BP1 down-regulation (average fold change by qRT-PCR: 5.9) and 3 control samples with average A2BP1 levels, followed by RT-PCR validation.
Limitations
- The paper does not include a dedicated limitations section.
- The text makes evident that the RNA-Seq comparison used a very small sample (3 ASD, 3 controls) and the replication cohort was also small (9 ASD, 5 controls).
- The study relies on post-mortem brain tissue; potential confounders such as age, sex, RNA integrity number, post-mortem interval, seizure co-morbidity, and medication were assessed, but the authors state that immune changes have no evidence of a common genetic component and are most likely secondary or environmental.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 8 Not checked · 93 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“The hubs of M12, i.e. the genes with the highest rank of M12 membership 8 , were A2BP1, APBA2, SCAMP5, CNTNAP1, KLC2, CHRM1 (Supplementary Data).”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The citation is attached to the definition of module membership used to identify hubs, not to the six-gene list, which the citing sentence attributes to its Supplementary Data. The Results section (“Module membership is highly consistent”; page unavailable) defines module membership, and the Methods section (“Defining a measure of module membership (kME)”; page unavailable) explains how genes are ranked by it. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The control brain network showed high similarity with the previously described human brain co-expression networks (Supplementary Table 7), consistent with the existence of robust modules of co-expressed genes related to specific cell types and biological functions 8 .”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The citation supports the sentence’s final clause: the Results sections ‘Conserved modules are enriched for markers of cell classes’ and ‘Relationships between modules are highly preserved’ describe reproducible co-expression modules associated with cell types and biological functions. The similarity of the citing authors’ control network to earlier networks is their own comparison, reported in their Supplementary Table 7, rather than a finding attributed to this source. Page numbers were not available in our copy. (LLM, conf=0.91)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“M12 showed significant overrepresentation of known autism susceptibility genes 2 (Supplementary Table 10; p = 6.1E-4), including CADPS2 , AHI1 , CNTNAP2 , and SLC25A12”
What the sources say
- Partly supportedcites [2] 2. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, Conroy J, Magalhaes TR, Correia C, Abrahams BS, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010; 466:368-372. [PubMed: 20531469] sourceExperimental — accuracy not yet measured
The main text (Figure 2 and the accompanying results; page not provided) discusses a set of ASD-implicated genes, supporting the general description attached to citation 2. Our copy does not identify CADPS2, AHI1, CNTNAP2, or SLC25A12 as members of that set, so it cannot verify the specific examples. The M12 enrichment and p value are presented as the citing paper’s own analysis, not as findings of this source. (LLM, conf=0.77)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The first three of these genes have previously been implicated in autism 14-16”
What the sources say
- Not checked — no full text of the sourcecites [14] 14. Babatz TD, Kumar RA, Sudi J, Dobyns WB, Christian SL. Copy number and sequence variants implicate APBA2 as an autism candidate gene. Autism Res. 2009; 2:359-364. [PubMed: 20029827] source
- Supportedcites [15] 15. Castermans D, Volders K, Crepel A, Backx L, De Vos R, Freson K, Meulemans S, Vermeesch JR, Schrander-Stumpel CT, De Rijk P, et al. SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles. Hum Mol Genet. 2010; 19:13681378. [PubMed: 20071347] source
The Abstract identifies SCAMP5 as a candidate gene for autism and reports its disruption in a patient with autism. In the citing sentence’s group of three references, this paper supports the SCAMP5 portion of the claim. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [16] 16. Martin CL, Duvall JA, Ilkin Y, Simon JS, Arreaza MG, Wilkes K, Alvarez-Retuerto A, Whichello A, Powell CM, Rao K, et al. Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet. 2007; 144B:869-876. [PubMed: 17503474] source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“showed significant similarity to two modules identified in previous studies of normal human brain 8 : an astrocyte module and a microglial module.”
What the sources say
- Supportedcites [8] 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] source
The Results section identifies a module of coexpressed genes with characteristics of microglia in human brain. The citation identifies the earlier microglial module; the statement that the citing study’s M16 was significantly similar to it is the citing authors’ comparison, not a finding attributed to Oldham et al. No page number is available in our copy. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
95 more claims · 6 with their cited sources checked
Create a free account to see all 117 claims and every source verdict.
- It may state two separate claims as one. 14
- Probably not a substantial claim. 5
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Although there was no significant DGE in the cerebellum (FDR < 0.05, P distributions in Fig. 1b), similar to observations in a smaller cohort8, there was a replication signal in the cerebellum and overall concordance between ASD-related fold changes in the cortex and cerebellum (Extended Data Fig. 2f–h).”
From Genome-wide changes in lncRNA, splicing, and regional gene expression patterns in autism (2016) · cites this paper as [8]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These results are consistent with previous studies in post-mortem brain that identified dysregulation of gene expression in microglia but enriched expression of ASD risk genes only in neuronal cells (Ruzzo et al., 2019; Gandal et al., 2018a, 2018b; Voineagu et al., 2011).”
From Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism (2020) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gene expression changes in postmortem brain overlap with developmentally regulated genes involved in cortical patterning as well as in cell cycle, proliferation and neural differentiation6, 7.”
From Altered proliferation and networks in neural cells derived from idiopathic autistic individuals (2017) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upregulation of immune genes and downregulation of synaptic genes was observed in postmortem brain from idiopathic ASD (Voineagu et al., 2011), and this finding has been replicated in a larger ASD sample (Gupta et al., 2014).”
From Getting to the cores of autism (2019) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This hypothesis was supported both by the significant overlap between candidate autism-susceptibility genes and Rbfox target genes and by the significant overlap of predicted Rbfox target exons and exons altered in autistic brains with down-regulation of Rbfox1 (Voineagu et al., 2011).”
From HITS-CLIP and integrative modeling define the Rbfox splicing-regulatory network linked to brain development and autism (2014) · cites this paper as Voineagu et al., 2011
Experimental — accuracy not yet measured
81 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Self-citationA General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684 · cited 5×
“We next applied weighted-gene co-expression network analysis (WGCNA) 8; 9 to integrate the expression differences observed between autistic and control cerebral cortex into a higher order, systems level context.”
InfluentialSelf-citationPan, Q., Shai, O., Lee, L. J., Frey, B. J., & Blencowe, B. J. (2008) · Nature Genetics · doi:10.1038/ng.259 · Cited by 3,951
Self-citationCahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Strong association of de novo copy number mutations with autism
Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., et al. (2007) · Science · doi:10.1126/science.1138659 · Cited by 2,795
Self-citationFunctional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 1×
“These results indicate that (1) M12 consists of a set of genes that are supported by independent lines of evidence to be causally involved in ASD pathophysiology, and (2) the upregulation of immune response genes in the autistic brain observed by us and others(25) has no evidence of a common genetic component.”
Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R
Langfelder, P., Zhang, B., & Horvath, S. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btm563 · Cited by 1,892
Self-citationAdvances in autism genetics: on the threshold of a new neurobiology
Abrahams, B. S., & Geschwind, D. H. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2346 · Cited by 1,866 · cited 3×
“%) showed significant overlap with the previously described human brain modules (Supplementary Table 6), indicating that many features reflecting the general organization of the autism brain transcriptome are consistent with that of the normal human brain.”
InfluentialSelf-citationDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602
Amaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492 · cited 1×
“In addition, comparison of these DE results with another, smaller study of the STG in ASD 7 , revealed significant consistency at the level of DE genes, including down-regulation of DLX1 and AHI1 (Supplementary Table 5).”
Research works printed but not linked: 1
- 8. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S, Geschwind DH. Functional organization of the transcriptome in human brain. Nat Neurosci. 2008; 11:1271-1282. [PubMed: 18849986] · DOI · Paper page
Cited by
Items 601–700 of 1,888
A systematic variant annotation approach for ranking genes associated with autism spectrum disorders
Larsen, E., Menashe, I., Ziats, M. N., Pereanu, W., Packer, A., & Banerjee-Basu, S. (2016) · Molecular Autism · doi:10.1186/s13229-016-0103-y · Cited by 49
“4b), a gene for which considerable functional evidence exists including its role in regulating other ASD genes [27, 28] and its involvement in ASD pathogenesis as manifested by differential expression in postmortem brain of ASD individuals [29].”
BackgroundHwang, H., Szucs, M. J., Ding, L. J., Allen, A., Ren, X., Haensgen, H., Gao, F., Rhim, H., Andrade, A., Pan, J. Q., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.07.014 · Cited by 49
Ellis, S. E., Panitch, R., West, A. B., & Arking, D. E. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.87 · Cited by 48
“11,12 In particular, a marked increase was observed in gene expression related to alternative activation of the innate immune system, or the M2 response in AUT-affected brains, relative to controls.”
InfluentialEpigenetic Mechanisms in Autism Spectrum Disorder
Zhubi, A., Cook, E. H., Guidotti, A., & Grayson, D. R. (2014) · International review of neurobiology · doi:10.1016/b978-0-12-801311-3.00006-8 · Cited by 61
“ASD that are shared with related neurodevelopmental disorders may be explained through altered gene expression profiles filtered through various epigenetic mechanisms (Lasalle, 2013; Miyauchi & Voineagu, 2013; Voineagu et al., 2011).”
BackgroundiPSC-derived neurons as a higher-throughput readout for autism: promises and pitfalls
Prilutsky, D., Palmer, N. P., Smedemark-Margulies, N., Schlaeger, T. M., Margulies, D. M., & Kohane, I. S. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.11.004 · Cited by 48
Merging Data from Genetic and Epigenetic Approaches to Better Understand Autistic Spectrum Disorder
Grayson, D. R., & Guidotti, A. (2015) · Epigenomics · doi:10.2217/epi.15.92 · Cited by 56
Zhang, R., Zhou, J., Ren, J., Sun, S., Di, Y., Wang, H., An, X., Zhang, K., Zhang, J., Qian, Z., et al. (2018) · Reproductive Toxicology · doi:10.1016/j.reprotox.2018.01.008 · Cited by 49
Self-citationOsenberg, S., Karten, A., Sun, J., Li, J., Charkowick, S. V., Felice, C. A., Kritzer, M. F., Nguyen, M. V. C., Yu, P., & Ballas, N. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1722546115 · Cited by 50
“In addition, accumulating evidence indicates that many of the genes, which are mutated in autism spectrum disorder, represent crucial components of the activity-dependent signaling networks that regulate synaptic plasticity (28, 39, 43, 44).”
BackgroundIdentification and replication of RNA-Seq gene network modules associated with depression severity
Le, T. T., Savitz, J. B., Suzuki, H., Misaki, M., Teague, T. K., White, B. C., Marino, J. H., Wiley, G. B., Gaffney, P. M., Drevets, W. C., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0234-3 · Cited by 53
Resolving the Synaptic versus Developmental Dichotomy of Autism Risk Genes
Heavner, W. E., & Smith, S. E. P. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.01.009 · Cited by 53
“Transcriptomic analyses pointed to modules of co-expressed genes associated with neuron function and immune activation; the former correlated with genetic variants while the latter did not, suggesting a cause-effect relationship [16].”
Neuronal and glial cell number is altered in a cortical layer-specific manner in autism
Falcone, C., Mevises, N.-Y., Hong, T., Dufour, B. D., Chen, X., Noctor, S. C., & Martínez‐Cerdeño, V. (2021) · Autism · doi:10.1177/13623613211014408 · Cited by 54
“In addition, gene coexpression network analysis comparing ASD and control brains showed that regional patterns that usually distinguish frontal and temporal cortices are altered in the ASD, pointing also to abnormalities in cortical patterning (Voineagu et al., 2011).”
BackgroundAllard, M., Bergeron, J. D., Baharnoori, M., Srivastava, L. K., Fortier, L., Poyart, C., & Sébire, G. (2017) · Autism Research · doi:10.1002/aur.1647 · Cited by 48
“…mostly characterized by atypical neuronal and axonal network developments, such as disconnectivity within the corpus callosum, frontal and parietal cortical and subcortical white matter areas [Ameis & Catani, 2015; Ameis & Szatmari, 2012; Voineagu et al., 2011; Zikopoulos & Barbas, 2010].”
BackgroundPistollato, F., Forbes-Hernández, T. Y., Iglesias, R. C., Ruíz, R., Elexpuru-Zabaleta, M., Cianciosi, D., Giampieri, F., & Battino, M. A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104579 · Cited by 52
Discovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms
Uzun, E. D. G., Sciarra, L. N., Maguire, A. M., Pescosolido, M. F., van Dyck, L. I., & Morrow, E. M. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0363-9 · Cited by 50
Exploring Transcription Factors-microRNAs Co-regulation Networks in Schizophrenia
Xu, Y. J., Yue, W., Shugart, Y. Y., Li, S., Cai, L., Li, Q., Cheng, Z., Wang, G., Zhou, Z., Jin, C., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv170 · Cited by 46
Mizoguchi, Y., & Monji, A. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00069 · Cited by 47
“…constantly use highly motile processes to survey their assigned brain regions and phagocyte pathogens and cellular debris even in their resting state, and are ready to transform to ‘‘activated’’ state in responses to injury, ischemia or autoimmune challenges in the brain (Wake et al., 2013).”
BackgroundA Primate-Specific Isoform of PLEKHG6 Regulates Neurogenesis and Neuronal Migration
O’Neill, A. C., Kyrousi, C., Klaus, J., Leventer, R. J., Kirk, E. P., Fry, A. E., Pilz, D. T., Morgan, T., Jenkins, Z. A., Drukker, M., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.029 · Cited by 55
The Contribution of Inflammation to Autism Spectrum Disorders: Recent Clinical Evidence
Prata, J., Machado, A. S., von Doellinger, O., Almeida, M. I., Barbosa, M. A., Coelho, R. C., & Santos, S. G. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9554-7_29 · Cited by 48
Berto, S., Treacher, A., Caglayan, E., Luo, D., Haney, J. R., Gandal, M. J., Geschwind, D. H., Montillo, A., & Konopka, G. (2022) · Nature Communications · doi:10.1038/s41467-022-31053-5 · Cited by 54
Self-citationRen, Y. X., Cui, Y., Li, X., Wang, B., Long, N., Shi, J., Wang, L., Qiu, L., Zhang, K., Liu, G., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.05.002 · Cited by 49
Zhang, S., Samocha, K. E., Rivas, M. A., Karczewski, K. J., Daly, E., Schmandt, B., Neale, B. M., MacArthur, D. G., & Daly, M. J. (2018) · Genome Research · doi:10.1101/gr.231902.117 · Cited by 48
“…disease, familial dysau-tonomia, schizophrenia, autism spectrum disorder and various types of cancers (Lorson et al. 1999; Radisky et al. 2005; Ibrahim et al. 2006; Law et al. 2007; Samaranch et al. 2010; Poulikakos et al. 2011; Tanackovic et al. 2011; Voineagu et al. 2011; Ferrarese et al. 2014).”
Kissel, L. T., & Werling, D. M. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.11.023 · Cited by 46
“(16) reported an ASD-down-regulated neuronal module (M12) associated with 124 synaptic function, vesicular transport, and neuronal projection, and Gupta et al.”
BackgroundInfluentialThomas, M. A., & Klaper, R. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032917 · Cited by 54
Current Progress and Challenges in the Search for Autism Biomarkers
Voineagu, I., & Yoo, H. J. (2013) · Disease Markers · doi:10.1155/2013/476276 · Cited by 45
“However, a common theme of these studies was the upregulation of genes involved in immune and inflammatory responses, consistent with gene expression studies on postmortem brain [72, 73] and neuropathological studies [74, 75].”
ResultSelf-citationBuckberry, S., Bianco‐Miotto, T., Bent, S. J., Clifton, V. L., Shoubridge, C., Shankar, K., & Roberts, C. T. (2017) · BMC Genomics · doi:10.1186/s12864-016-3384-9 · Cited by 45
The contribution of alternative splicing to genetic risk for psychiatric disorders
Reble, E., Dineen, A., & Barr, C. L. (2017) · Genes Brain & Behavior · doi:10.1111/gbb.12430 · Cited by 52
“patients with ASD, with these tissues also having a misregulation of 5 to 10% of alternative exons.(55,56) Analysis of the RBFOX targets identified 48 of these as previously identified ASD candidates in the SFARI database(56) indicating that RBFOX may contribute to disease by deregulating these target genes.”
BackgroundSynapse-to-Nucleus Signaling in Neurodegenerative and Neuropsychiatric Disorders
Parra‐Damas, A., & Saura, C. A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.01.006 · Cited by 55
Advances in Biomarker Studies in Autism Spectrum Disorders
Shen, L., Zhao, Y., Zhang, H., Feng, C., Gao, Y. L., Zhao, D., Xia, S., Qi, H., Iqbal, J., Liu, X., et al. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_11 · Cited by 52
scLink: Inferring Sparse Gene Co-Expression Networks from Single-Cell Expression Data
Li, W. V., & Li, Y. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2020.11.006 · Cited by 47
“For instance, transcriptional dysregulation revealed by disease-associated gene interactions has been reported in various diseases including cancer [4], neurological disorders [5], and psychiatric disorders [6], leading to functional insights of transcriptome organization in disease progression.”
Atypical genomic cortical patterning in autism with poor early language outcome
Lombardo, M. V., Eyler, L. T., Pramparo, T., Gazestani, V., Hagler, D. J., Chen, C., Dale, A. M., Seidlitz, J., Bethlehem, R. A. I., Bertelsen, N., et al. (2021) · Science Advances · doi:10.1126/sciadv.abh1663 · Cited by 47
RNA splicing regulators play critical roles in neurogenesis
Fisher, E., & Feng, J. (2022) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1728 · Cited by 47
“RBFOX genes have been identified as candidate genes for autism spectrum disorder (Voineagu et al., 2011), human epilepsy syndromes (Martin et al.”
BackgroundMicroglia Modulate Neurodevelopment in Autism Spectrum Disorder and Schizophrenia
Fan, G., Ma, J., Ma, R., Suo, M., Chen, Y., Zhang, S., Zeng, Y., & Chen, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417297 · Cited by 56
“As a result, murine models have become essential resources for elucidating these mechanisms and developing targeted interventions, both of which are discussed in greater depth in the following sections.”
BackgroundAutism spectrum disorder in children born preterm—role of exposure to perinatal inflammation
Meldrum, S. J., Strunk, T., Currie, A., Prescott, S. L., Simmer, K., & Whitehouse, A. J. O. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00123 · Cited by 45
“The first comprehensive gene-expression analysis of the CNS in patients with ASD (Voineagu et al., 2011), observed that immune genes and glial markers were over-expressed, supporting the findings of immune dysregulation in ASD.”
BackgroundMaxeiner, S., Glassmann, A., Kao, H., & Schilling, K. (2013) · Histochemistry and Cell Biology · doi:10.1007/s00418-013-1159-9 · Cited by 50
“Conversely, an increasing number of neuropsychiatric diseases is being recognized to be associated with aberrant splicing (e.g., Dubuc et al. 2012; Voineagu et al. 2011).”
BackgroundImaging-Genetics in Autism Spectrum Disorder: Advances, Translational Impact, and Future Directions
Ameis, S. H., & Szatmari, P. (2012) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2012.00046 · Cited by 45
Hypermethylation of the enolase gene (ENO2) in autism
Wang, Y., Fang, Y., Zhang, F., Xu, M., Zhang, J., Yan, J., Ju, W., Brown, W. T., & Zhong, N. A. (2014) · European Journal of Pediatrics · doi:10.1007/s00431-014-2311-9 · Cited by 48
“From Table 2, four genes LASS3, PANX2, SLC15A4, and ENO2 were selected for further study based on the following concerns: (1) significant difference of methylation status among these genes that were identified with MeDIP array in five pairs of autism-control cases; (2) gene function(s), more importantly, their potenti…”
BackgroundBerg, J. M., Lee, C., Chen, L., Galvan, L., Cepeda, C., Chen, J. Y., Peñagarikano, O., Stein, J. L., Li, A., Oguro-Ando, A., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.10.031 · Cited by 45
“A critical goal of research in etiologically complex neurodevelopmental disorders such as ASD is to identify potentially convergent molecular pathways (Parikshak et al., 2013; Voineagu et al., 2011).”
Self-citationRoles of Glial Cells in Sculpting Inhibitory Synapses and Neural Circuits
Um, J. W. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00381 · Cited by 48
“In addition, microglial activation has been demonstrated in the brains of individuals with ASD or schizophrenia (van Berckel et al., 2008; Voineagu et al., 2011).”
Molecular windows into the human brain for psychiatric disorders
Egervári, G., Kozlenkov, A., Dracheva, S. M., & Hurd, Y. L. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0125-2 · Cited by 47
Colonic dilation and altered ex vivo gastrointestinal motility in the neuroligin‐3 knockout mouse
Leembruggen, A. J. L., Balasuriya, G. K., Zhang, J., Schokman, S., Swiderski, K., Bornstein, J. C., Nithianantharajah, J., & Hill‐Yardin, E. L. (2019) · Autism Research · doi:10.1002/aur.2109 · Cited by 50
“in 10–20% of autism cases, rare genetic mutations that are thought to underlie the core symptoms are expressed [Betancur, 2011; Geschwind, 2011; Voineagu et al., 2011].”
BackgroundBahado-Singh, R. O., Vishweswaraiah, S., Aydas, B., Mishra, N. K., Yılmaz, A., Guda, C., & Radhakrishna, U. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146457 · Cited by 51
CoCoCoNet: conserved and comparative co-expression across a diverse set of species
Lee, J., Shah, M., Ballouz, S., Crow, M., & Gillis, J. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa348 · Cited by 41
“in autism (10), Parkinson’s disease (11) and heart disease (12)] and as an important contributor to sophisticated algorithms for inferring gene properties [e.”
BackgroundHughes, H. K., Rowland, M. E., Onore, C. E., Rogers, S. J., Ciernia, A. V., & Ashwood, P. (2022) · Translational Psychiatry · doi:10.1038/s41398-021-01766-0 · Cited by 61
Pediatric psychopharmacology: Too much or too little?
Rapoport, J. L. (2013) · World Psychiatry · doi:10.1002/wps.20028 · Cited by 44
“Post-mortem human brain studies may ultimately generate new targets, as gene expression studies of post-mortem brains in autism have implicated pathways for both brain development and immune responses (67).”
BackgroundHeterogeneity and convergence: the synaptic pathophysiology of autism
Baudouin, S. J. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12498 · Cited by 46
“The splicing factor A2BP1/FOX1 has been shown at the center of a gene cluster that is dysregulated in ASD (Voineagu et al., 2011).”
BackgroundRodriguez‐Fontenla, C., & Carracedo, Á. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01378-8 · Cited by 47
Oxotremorine treatment reduces repetitive behaviors in BTBR T+ tf/J mice
Amodeo, D. A., Yi, J., Sweeney, J. A., & Ragozzino, M. E. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00017 · Cited by 50
“In particular, there are results from gene networks that confer risk of ASD that include genes related to cholinergic transmission (Voineagu et al., 2011; Ben-David and Shifman, 2012; Lee et al., 2012) and post-mortem studies indicating reduced brain mAChR expression in ASD individuals (Deutsch et…”
AlzBase: An Integrative Database for Gene Dysregulation in Alzheimer’s Disease
Bai, Z., Han, G., Xie, B., Wang, J., Song, F., Peng, X., & Lei, H. (2016) · Molecular Neurobiology · doi:10.1007/s12035-014-9011-3 · Cited by 44
“For comparison, we also included several neurological disorders including PD, schizophrenia, autism, and some other diseases [23–33] (GEO datasets shown in Supplementary Table 2).”
BackgroundAberrant splicing in neurological diseases
Feng, D., & Xie, J. (2013) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1184 · Cited by 48
Narzo, A. F. D., Kozlenkov, A., Roussos, P., Hao, K., Hurd, Y. L., Lewis, D. A., Sibille, E. L., Siever, L. J., Koonin, E. V., & Dracheva, S. M. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu195 · Cited by 45
Kao, C.-Y., He, Z., Zannas, A. S., Hahn, O., Kühne, C., Reichel, J. M., Binder, E. B., Wotjak, C. T., Khaitovich, P., & Turck, C. W. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.02.003 · Cited by 49
Furlan, S. N., Watkins, B. K., Tkachev, V., Cooley, S., Panoskaltsis‐Mortari, A., Betz, K., Brown, M., Hunt, D. J., Schell, J. B., Zeleski, K., et al. (2016) · Blood · doi:10.1182/blood-2016-07-726547 · Cited by 46
Regulatory genes and pathways disrupted in autism spectrum disorders
Ayhan, F., & Konopka, G. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.017 · Cited by 50
Sleep as a translationally-relevant endpoint in studies of autism spectrum disorder (ASD)
Missig, G., McDougle, C. J., & Carlezon, W. A. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0409-5 · Cited by 53
The Endocannabinoid System as a Window Into Microglial Biology and Its Relationship to Autism
Araujo, D. J., Tjoa, K., & Saijo, K. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00424 · Cited by 51
Proteomic Investigations of Autism Brain Identify Known and Novel Pathogenetic Processes
Abraham, J. R., Szoko, N., Barnard, J., Rubin, R. A., Schlatzer, D., Lundberg, K. C., Li, X., & Natowicz, M. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-49533-y · Cited by 45
Human in vitro models for understanding mechanisms of autism spectrum disorder
Gordon, A., & Geschwind, D. H. (2020) · Molecular Autism · doi:10.1186/s13229-020-00332-7 · Cited by 47
Self-citationImmune regulation of neurodevelopment at the mother–foetus interface: the case of autism
Sotgiu, S., Manca, S., Gagliano, A., Minutolo, A., Melis, M. C., Pisuttu, G., Scoppola, C., Bolognesi, E., Clerici, M., Guerini, F. R., et al. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1211 · Cited by 44
Three decades of ASD genetics: building a foundation for neurobiological understanding and treatment
Eyring, K. W., & Geschwind, D. H. (2021) · Human Molecular Genetics · doi:10.1093/hmg/ddab176 · Cited by 50
“In addition to this convergence at the genetic level, there is strong evidence for convergence in genomic data from post-mortem ASD brain (61,65,112), motivating systems biology approaches.”
BackgroundSelf-citationMattioli, F., Hayot, G., Drouot, N., Isidor, B., Courraud, J., Hinckelmann, M.-V., Mau-Them, F. T., Sellier, C., Goldman, A., Telegrafi, A., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.02.013 · Cited by 42
“Its expression was found to be reduced in brains collected postmortem from individuals with ASD leading to alteration of splicing of its predicted targets such as GRIN1 or MEF2C.35 Moreover, structural variants affecting RBFOX1 have been reported in several individuals with ASD, epilepsy, and ID.36–38 Mis-regulation o…”
BackgroundZhang, P., Omanska-Klusek, A., Ander, B. P., Gandal, M. J., Stamova, B. S., & Schumann, C. M. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2206758120 · Cited by 57
Making sense of deep sequencing
Goldman, D., & Domschke, K. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000789 · Cited by 43
“…the transcriptome level, 212 significant differential splicing (DS) events dependent on the neuronal specific splicing factor A2BP1 were identified in post-mortem brain tissue samples of patients with autism spectrum disorders using high-throughput RNA-sequencing (RNA-Seq) (Voineagu et al., 2011).”
Jalbrzikowski, M., Lázaro, M. T., Gao, F., Huang, A., Chow, C. C., Geschwind, D. H., Coppola, G., & Bearden, C. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132542 · Cited by 57
“To validate our gene expression andWGCNA results, we conducted hypergeometric probability tests (phyper function in R) between our results and publicly available datasets related to idiopathic psychosis [58] and ASD [59].”
ResultSelf-citationMiR-980 Is a Memory Suppressor MicroRNA that Regulates the Autism-Susceptibility Gene A2bp1
Guven-Ozkan, T., Busto, G. U., Schutte, S. S., Cervantes-Sandoval, I., O’Dowd, D. K., & Davis, R. L. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.040 · Cited by 45
Chen, J., Yu, L., Zhang, S., & Chen, X. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00615 · Cited by 47
Zheng, W., Zou, Z., Lin, S., Chen, X., Wang, F., Li, X., & Dai, J. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27677 · Cited by 44
Yang, G., & Shcheglovitov, A. (2019) · Developmental Dynamics · doi:10.1002/dvdy.100 · Cited by 47
Identification of amygdala-expressed genes associated with autism spectrum disorder
Herrero, M. J., Velmeshev, D., Hernandez-Pineda, D., Sethi, S., Sorrells, S., Banerjee, P., Sullivan, C., Gupta, A. R., Kriegstein, A. R., & Corbin, J. G. (2020) · Molecular Autism · doi:10.1186/s13229-020-00346-1 · Cited by 43
“terns are altered in the brains of individuals with a variety of neurodevelopmental disorders, including ASD [13, 19, 20].”
BackgroundMartin‐de‐Saavedra, M. D., Santos, M. D., Culotta, L., Varea, O., Spielman, B. P., Parnell, E., Forrest, M. P., Gao, R., Yoon, S., McCoig, E., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.11.025 · Cited by 52
“PMCA2 genetic variation has also been implicated in ASD (Takata et al., 2018); it has been observed that individuals with ASD present with reduced PMCA2 protein levels in brain tissue (Voineagu et al., 2011), and reduced mRNA levels in lymphoblasts (Stafford et al., 2017).”
Prenatal air pollution, maternal immune activation, and autism spectrum disorder
Yu, X., Rahman, M. M., Carter, S., Lin, J. C., Zhuang, Z., Chow, T., Lurmann, F., Kleeman, M. J., Martinez, M. P., van Donkelaar, A., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108148 · Cited by 53
Altered social behavior in mice carrying a corticalFoxp2deletion
Medvedeva, V. P., Rieger, M. A., Vieth, B., Mombereau, C., Ziegenhain, C., Ghosh, T., Cressant, A., Enard, W., Granon, S., Dougherty, J. D., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy372 · Cited by 45
Spatiotemporal dynamics of the postnatal developing primate brain transcriptome
Bakken, T. E., Miller, J. A., Luo, R., Bernard, A., Bennett, J. L., Lee, C.-K., Bertagnolli, D., Parikshak, N. N., Smith, K. A., Sunkin, S. M., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv166 · Cited by 41
“Overall, these results support the hypothesis that ASD-related genes may be part of the same developmental pathway (6,7,53), which is distinct from other developmental disorders and can be studied in a non-human primatemodel system.”
BackgroundResultInfluentialSelf-citationVelotta, J. P., Jones, J., Wolf, C. J., & Cheviron, Z. A. (2016) · Molecular Ecology · doi:10.1111/mec.13661 · Cited by 47
The Many Faces of Microbiota-Gut-Brain Axis in Autism Spectrum Disorder
Gonçalves, C. L., Doifode, T., Rezende, V. L., Costa, M. A., Rhoads, J. M., & Soutullo, C. A. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122357 · Cited by 42
Re-emerging concepts of immune dysregulation in autism spectrum disorders
Erbescu, A., Papuc, S. M., Budișteanu, M., Arghir, A., & Neagu, M. T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1006612 · Cited by 58
“Among the significantly upregulated genes in postmortem ASD brain tissues, many were identified to be involved in immune and inflammatory response and other immune regulatory processes (33, 34).”
BackgroundMicroglial contribution to the pathology of neurodevelopmental disorders in humans
Matulevičiūtė, R., Akinluyi, E. T., Muntslag, T. A. O., Dewing, J. M., Long, K. R., Vernon, A. C., Tremblay, M., & Menassa, D. A. (2023) · Acta Neuropathologica · doi:10.1007/s00401-023-02629-2 · Cited by 44
“Transcriptomically, earlier bulk-sequencing of cortical areas suggests a convergence of ASC pathology towards innate immune and neuronal dysfunctions [58, 148, 207].”
BackgroundSircar, S., & Parekh, N. (2015) · Frontiers in Genetics · doi:10.3389/fgene.2015.00256 · Cited by 44
“Keywords: functional annotation, co-expression, drought, rice, WGCNA Introduction Interpretation of high-throughput data for rice toward improving its yield under varying environmental conditions is largely limited by the incomplete functional annotation of rice genes.”
BackgroundKroon, T., Sierksma, M. C., & Meredith, R. M. (2013) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2013.00075 · Cited by 41
Pistoni, M., Shiue, L., Cline, M., Bortolanza, S., Neguembor, M. V., Xynos, A., Ares, M., & Gabellini, D. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003186 · Cited by 40
“Since the same symptoms are caused by Rbfox1 mutation or down-regulation [64–73], it is tempting to speculate that Rbfox1 down-regulation could be involved in the neurological manifestations of FSHD.”
BackgroundZhao, W.-W. (2013) · Molecular Cytogenetics · doi:10.1186/1755-8166-6-26 · Cited by 46
“Since then, constitutional genetic defects in RBFOX1 are implicated in multiple medical conditions including mental retardation and epilepsy [7], bipolar schizoaffective disorder [8], attention-deficit hyperactivity disorder (ADHD) [9], autism [10-13], hand osteoarthritis [14], congenital heart defects [15], obesity a…”
InfluentialNeuroinflammation — using big data to inform clinical practice
Dendrou, C. A., McVean, G., & Fugger, L. H. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.171 · Cited by 50
“For example, in patients with autism spectrum disorder (ASD), genes co-expressed in patient but not control brain tissue include those with immune and glial function 67,68 .”
BackgroundInsulin-Like Growth Factors in the Pathogenesis of Neurological Diseases in Children
Riikonen, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102056 · Cited by 40
Exaggerated CpH methylation in the autism-affected brain
Ellis, S., Gupta, S., Moes, A., West, A. B., & Arking, D. E. (2017) · Molecular Autism · doi:10.1186/s13229-017-0119-y · Cited by 43
“Recent genetic studies have identified a handful of genes that contribute to autism [2], and gene expression studies have begun to unravel how altered gene expression manifests within the autistic brain [3, 4]; however, the majority of risk remains unexplained.”
BackgroundDavis, L. K., Gamazon, E. R., Kistner-Griffin, E., Badner, J. A., Liu, C., Cook, E. H., Sutcliffe, J. S., & Cox, N. J. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-3 · Cited by 40
“Anney and colleagues in the AGP also conducted a novel analysis of the present genome-wide data utilizing the SNP ratio test in an effort to detect over-transmitted SNPs in predefined pathways of interest, which subsequently identified multiple pathways and/or Gene Ontology terms enriched for associated signals [23].”
MethodPolyphenism of a Novel Trait Integrated Rapidly Evolving Genes into Ancestrally Plastic Networks
Casasa, S., Biddle, J. F., Koutsovoulos, G., & Ragsdale, E. J. (2020) · Molecular Biology and Evolution · doi:10.1093/molbev/msaa235 · Cited by 47
Han, V. X., Jones, H. F., Patel, S., Mohammad, S. S., Hofer, M. J., Alshammery, S., Maple-Brown, E., Gold, W. A., Brilot, F., & Dale, R. C. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.09.009 · Cited by 43
Extending the phenotypic spectrum of RBFOX 1 deletions: Sporadic focal epilepsy
Lal, D., Pernhorst, K., Klein, K. M., Reif, P., Tozzi, R., Toliat, M. R., Winterer, G., Neubauer, B., Nürnberg, P., Rosenow, F., et al. (2015) · Epilepsia · doi:10.1111/epi.13076 · Cited by 40
“It plays a key role in the control of neuronal excitation in the mammalian brain and influences susceptibility to epilepsy.(4,5) Notably, brain-specific homozygous and heterozygous Rbfox1 knockouts in mice do not alter brain morphology but display spontaneous seizures and a dramatic epileptogenic response to kainic ac…”
BackgroundPossible sexually dimorphic role of miRNA and other sncRNA in ASD brain
Schumann, C. M., Sharp, F. R., Ander, B. P., & Stamova, B. (2017) · Molecular Autism · doi:10.1186/s13229-017-0117-0 · Cited by 39
“Our own molecular studies, and many others, have demonstrated clear age-related changes in the brains of both typically developing and autistic individuals [17, 18, 24, 56].”
ResultYu, Q., & He, Z. (2017) · Scientific Reports · doi:10.1038/s41598-017-04356-7 · Cited by 39
Brown, E. A., Lautz, J. D., Davis, T. R., Gniffke, E. P., VanSchoiack, A. A. W., Neier, S. C., Tashbook, N., Nicolini, C., Fahnestock, M., Schrum, A. G., et al. (2018) · Molecular Autism · doi:10.1186/s13229-018-0229-1 · Cited by 39
“An analogous network-level dysregulation has been observed in transcriptomic analysis of postmortem autism brain tissue, where individual mRNAs show normal levels of abundance, but the coordinated expression of mRNAs is dysregulated, reflecting disrupted regulatory mechanisms [18].”
BackgroundEpigenomic Convergence of Neural-Immune Risk Factors in Neurodevelopmental Disorder Cortex
Ciernia, A. V., Laufer, B. I., Hwang, H., Dunaway, K. W., Mordaunt, C. E., Coulson, R. L., Yasui, D. H., & LaSalle, J. M. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz115 · Cited by 42
“2016), as well as previous transcriptional and epigenomic profiling in human ASD brain that has consistently revealed both synaptic and immune dysfunction (Voineagu et al. 2011; Gupta et al. 2014; Gandal et al. 2016; Lin et al. 2016; Parikshak et al. 2016).”
BackgroundMethodAn integrated transcriptomic analysis of autism spectrum disorder
He, Y., Zhou, Y., Ma, W., & Wang, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-48160-x · Cited by 44
Inhibition-Based Biomarkers for Autism Spectrum Disorder
Levin, A. R., & Nelson, C. A. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0350-1 · Cited by 39
“Postmortem gene expression studies have demonstrated that, compared with controls, in addition to genes related to synaptic function, genes related to immune reactivity are overexpressed in brains of individuals with ASD [44].”
BackgroundWu, C., Huang, Z., Meng, Z., Fan, X., Lu, S., Tan, Y., You, L., Huang, J., Stalin, A., Ye, P.-Z., et al. (2021) · Chinese Medicine · doi:10.1186/s13020-021-00534-y · Cited by 40
“Currently, WGCNA is used in several studies of complex human diseases [18–20], especially in cancers, such as lung cancer [21], breast cancer [22], cholangiocarcinoma [23], etc. Benefiting from it is special function, which can discover modules of highly correlated genes and correlate with modules…”
MethodXia, J., Zhang, C., Zhang, S., Li, F., Feng, M., Wang, X., & Liu, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068185 · Cited by 45
“10 and the absolute value of log2 ratio $1 [36,37].”
Self-citationImmune function genes CD99L2, JARID2 and TPO show association with autism spectrum disorder
Ramos, P. S., Sajuthi, S. P., Langefeld, C. D., & Walker, S. J. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-4 · Cited by 44
“[13], who used a complimentary approach to test for evidence of a genetic component for the up-regulation of immune response genes in the autistic brain using the same AGRE genotype data.”
BackgroundMethodInfluentialAddington, A. M., & Rapoport, J. L. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02478.x · Cited by 45
“This is a very new area of research with methodologies still being improved, but there is tremendous potential for diagnostic and treatment applications, as recently indicated for autism (Voineagu et al., 2011 ).”
BackgroundRole of environmental factors and epigenetics in autism spectrum disorders
Saxena, R., Babadi, M., Namvarhaghighi, H., & Roullet, F. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.05.002 · Cited by 47
Schwartzer, J. J., Koenig, C. M., & Berman, R. F. (2013) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2012.08.007 · Cited by 39
Challenges and opportunities for precision medicine in neurodevelopmental disorders
Chen, G. T., & Geschwind, D. H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114564 · Cited by 44
“In Voineagu et al. [98], postmortem brain samples from three different regions were sequenced in ASD cases and controls.”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., Mill, J., Cantor, R. M., Blencowe, B. J., & Geschwind, D. H.
- Affiliations
- University of California, Los Angeles (US)
- University of Toronto (CA)
- King's College London (GB)
- Corresponding author
- Geschwind, Daniel H.
- ORCID
- Venue
- Nature
- Published
- 2011-05-25
- Volume
- 474
- Issue
- 7351
- Pages
- 380-384
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3607626
- OpenAlex
- W1995647101
- Cited by
- 1,874
- References
- 38
- Citations by year
- 2026: 91 · 2025: 93 · 2024: 95 · 2023: 111 · 2022: 112 · 2021: 141 · 2020: 131 · 2019: 142 · 2018: 132 · 2017: 127 · 2016: 143 · 2015: 136 · 2014: 137 · 2013: 124 · 2012: 120
- FWCI
- 67.49
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Autism Speaks
- Genome Canada
- Ontario Genomics Institute
- National Institutes of Health (5r01mh094714-04)
- Canadian Institutes of Health Research
- Medical Research Council
- National Institute of Mental Health (R01-MH094714, R01MH081754, R37MH060233)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, transcriptome, gene co-expression network, splicing dysregulation, A2BP1, alternative exons, autism susceptibility genes, neuronal dysfunction, genetic heterogeneity
- MeSH terms
- RNA Splicing Factors, Autistic Disorder, Brain, Exons, Frontal Lobe, Gene Expression Regulation, Humans, Temporal Lobe, Transcription, Genetic, Case-Control Studies, RNA-Binding Proteins, Alternative Splicing, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.